Laurent C, Flores M, Chartier L, Huet S, et al. Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen. Br J Haematol 2023 May 22. doi: 10.1111/bjh.18881.
PMID: 37218065